Dr. David Eccleston is a consultant dermatologist with special interests include the use of injectable Botulinum toxins, Hyaluronic Acid Fillers and management of the complications arising therefrom. He also have an in-house Clinical Study facility and dedicated research staff, and have performed over 20 sponsored studies on 5 different Botulinum toxins, multiple HA fillers and other cosmetic injectables.

He is an International Faculty member of The Allergan Medical Institute, as well as participating in advisory boards for Merz, Galderma, Revance, Evolus and other aesthetic dermatology companies. I am a Key Opinion Leader for Allergan, Cutera, Alumier, Emblation and Evolus, and am recognized internationally as a trainer and speaker in the field of injectable aesthetic treatments.  He is a member of the British College of Aesthetic Medicine, the British Medical Association and am fully registered with the General Medical Council. He was the Inaugural President of the Society of Cosmetic Physicians and Surgeons.